Multiple Sclerosis International

Research Article

Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional Study

Table 3

(a) A summary of bivariate analyses of individuals with MS who are suffering depression. (b) A summary of bivariate analyses of individuals with MS who are suffering anxiety.
(a)
Bivariate analyses
Variable value
Gender .0840.459
Age (mean, SD)−.0670.557
Duration of MS −.125 0.268
Marital status .1740.123
Education .1420.208
EDSS score in the past 6 months −.0750.510
MS treatment status−.0770.499
Prescribed antidepressants .2220.047
PHQ-9 scores .7210.0001
GAD-7 .5870.0001
Anxiety (score 10 or more in GAD-7) .5600.0001
(b)
Bivariate analyses
Variable value
Gender .1700.131
Age (mean, SD).0840.461
Duration of MS .0480.672
Marital status .1290.254
Education .025 0.823
EDSS Score in the past 6 months .0340.765
MS treatment status.0530.638
Prescribed antianxiety medications .2030.070
PHQ-9 scores .6780.0001
GAD-7 .8550.0001
Depression (score 10 or more in PHQ-9).5600.0001